Yang J - Search Results

1

Chemotherapy vs. allogeneic transplantation as post molecular remission therapy in patients aged less than 60 years with Philadelphia-positive ALL.

Wang L, Du J, Huang A, Tang G, Gong S, Cheng H, Zhang W, Yang J, Wang J, Hu X. Wang L, et al. Among authors: yang j. Bone Marrow Transplant. 2020 Jan;55(1):245-248. doi: 10.1038/s41409-019-0514-4. Epub 2019 Mar 27. Bone Marrow Transplant. 2020. PMID: 30918339 No abstract available.

2

[A pilot study of spectrum of gene expression of acute leukemia].

Chen L, Wang JM, Xu XP, Li Y, Xu H, Ju XP, Ni X, Yang JM, Xu YQ. Chen L, et al. Zhonghua Yi Xue Za Zhi. 2005 Apr 27;85(16):1089-92. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029563 Chinese.

3

[Recipient lymphopenia state enhances the expansion and anti-leukemia effect of leukemia specific cytotoxic T lymphocytes].

Lou JW, Yang JM, Chen L, Jia XY, Zhang WP, Wang JM. Lou JW, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Aug;26(8):465-8. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16383236 Chinese.

4

Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients.

Song X, Gong S, Yang J, Wang J. Song X, et al. Among authors: yang j. Ann Hematol. 2007 May;86(5):347-51. doi: 10.1007/s00277-007-0255-0. Epub 2007 Jan 24. Ann Hematol. 2007. PMID: 17245591

5

[Effects of proteasome inhibitors on leukemias].

Lü SQ, Yang JM, Wang JM. Lü SQ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):896-900. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17708829 Review. Chinese.

6

[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].

Lü SQ, Yang JM, Song XM, Chen L, Zhang WP, Ni X, Xu XQ, Wang JM. Lü SQ, et al. Zhonghua Zhong Liu Za Zhi. 2007 Sep;29(9):710-2. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18246806 Chinese.

7

Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line.

Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Lü S, et al. Among authors: yang j. J Pharmacol Exp Ther. 2008 Aug;326(2):423-31. doi: 10.1124/jpet.108.138131. Epub 2008 May 23. J Pharmacol Exp Ther. 2008. PMID: 18502982

8

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line.

Lü S, Chen Z, Yang J, Chen L, Gong S, Zhou H, Guo L, Wang J. Lü S, et al. Among authors: yang j. Exp Hematol. 2008 Oct;36(10):1278-84. doi: 10.1016/j.exphem.2008.04.013. Epub 2008 Jun 17. Exp Hematol. 2008. PMID: 18562081 Free article.

9

[Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].

He Y, Yang JM, Wang JM, Zhou H, Lü SQ, Hu XX. He Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):794-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718063 Chinese.

10

Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience.

Lü S, Wang J, Xu X, Ni X, Huang C, Qiu H, Hu X, Yang J. Lü S, et al. Among authors: yang j. Int J Hematol. 2009 Jan;89(1):34-38. doi: 10.1007/s12185-008-0218-9. Epub 2008 Dec 13. Int J Hematol. 2009. PMID: 19082817 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,507 results

Search Page

Filters